HK1092708A1 - Polyacetal drug conjugates as release system - Google Patents

Polyacetal drug conjugates as release system

Info

Publication number
HK1092708A1
HK1092708A1 HK06113449.4A HK06113449A HK1092708A1 HK 1092708 A1 HK1092708 A1 HK 1092708A1 HK 06113449 A HK06113449 A HK 06113449A HK 1092708 A1 HK1092708 A1 HK 1092708A1
Authority
HK
Hong Kong
Prior art keywords
linker
occurrence
succinamide
polyacetal
release system
Prior art date
Application number
HK06113449.4A
Other languages
English (en)
Inventor
Mikhail I Papisov
Alexander Yurkovetskiy
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of HK1092708A1 publication Critical patent/HK1092708A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L59/00—Compositions of polyacetals; Compositions of derivatives of polyacetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK06113449.4A 2003-09-05 2006-12-06 Polyacetal drug conjugates as release system HK1092708A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50057103P 2003-09-05 2003-09-05
PCT/US2004/029130 WO2005023294A2 (fr) 2003-09-05 2004-09-04 Systeme de liberation de medicament en deux phase

Publications (1)

Publication Number Publication Date
HK1092708A1 true HK1092708A1 (en) 2007-02-16

Family

ID=34272970

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113449.4A HK1092708A1 (en) 2003-09-05 2006-12-06 Polyacetal drug conjugates as release system

Country Status (10)

Country Link
US (4) US7790150B2 (fr)
EP (1) EP1667726B1 (fr)
JP (3) JP5537763B2 (fr)
AT (1) ATE507845T1 (fr)
AU (1) AU2004270251B2 (fr)
CA (1) CA2537993C (fr)
DE (1) DE602004032553D1 (fr)
ES (1) ES2365918T3 (fr)
HK (1) HK1092708A1 (fr)
WO (1) WO2005023294A2 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106098B2 (en) * 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
DE60323936D1 (de) 2002-01-14 2008-11-20 Gen Hospital Corp Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
JP4800614B2 (ja) * 2002-07-19 2011-10-26 ザ ジェネラル ホスピタル コーポレイション オキシム結合体、およびそれらの形成および使用のための方法
DE602004032553D1 (de) 2003-09-05 2011-06-16 Gen Hospital Corp Polyacetal-arzneimittelkonjugate als freisetzungssystem
AU2006243960A1 (en) * 2005-05-10 2006-11-16 Emory University Strategies for delivery of active agents using micelles and particles
US8252846B2 (en) * 2005-05-10 2012-08-28 Emory University Strategies for delivery of active agents using micelles and particles
WO2007098041A1 (fr) 2006-02-17 2007-08-30 Medtronic, Inc. Polymeres de polycetal et leurs procedes de fabrication et d'utilisation
WO2008127532A1 (fr) * 2007-04-12 2008-10-23 Emory University Stratégies inédites d'administration d'agents actifs au moyen de micelles et de particules
US20080255175A1 (en) * 2007-04-16 2008-10-16 Lam Marina K Anti-cancer agents, compositions and methods of treating cancers
EP2217283A2 (fr) * 2007-11-28 2010-08-18 Mersana Therapeutics, Inc. Conjugués d'analogues de fumagilline biocompatibles et biodégradables
CL2009002167A1 (es) * 2008-12-10 2010-10-15 Mersana Therapeutics Inc Formulacion farmaceutica para administracion endovenosa que comprende un compuesto derivado de conjugados de camptotecina-polimero biocompatibles y biodegradables, un agente de estabilizacion, uno o varios tampones y un tensoactivo, util para el tratamiento del cancer.
US11090387B2 (en) 2008-12-22 2021-08-17 The Trustees Of The University Of Pennsylvania Hydrolytically degradable polysaccharide hydrogels
KR20120057588A (ko) * 2009-05-28 2012-06-05 메르사나 테라퓨틱스, 인코포레이티드 가변 속도 방출 링커를 포함하는 폴리알 약물 접합체
WO2010144881A1 (fr) * 2009-06-12 2010-12-16 The General Hospital Corporation Traitement de méningites et de maladies neuronales
US8349308B2 (en) 2010-03-26 2013-01-08 Mersana Therapeutics, Inc. Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
US9486404B2 (en) 2011-03-28 2016-11-08 The Trustees Of The University Of Pennsylvania Infarction treatment compositions and methods
US8815226B2 (en) 2011-06-10 2014-08-26 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
CN106110332B (zh) 2011-06-10 2018-11-30 梅尔莎纳医疗公司 蛋白质-聚合物-药物共轭物
US20140017265A1 (en) * 2012-07-05 2014-01-16 Mersana Therapeutics, Inc. Terminally Modified Polymers and Conjugates Thereof
WO2014093394A1 (fr) * 2012-12-10 2014-06-19 Mersana Therapeutics, Inc. Conjugués protéine-polymère-médicament
WO2014093379A1 (fr) * 2012-12-10 2014-06-19 Mersana Therapeutics, Inc. Composés auristatine et leurs conjugués
US9872918B2 (en) 2012-12-12 2018-01-23 Mersana Therapeutics, Inc. Hydroxyl-polymer-drug-protein conjugates
US20160022829A1 (en) * 2013-03-14 2016-01-28 Mersana Therapeutics, Inc. Tubulysin compounds and conjugates thereof
CN105979970B (zh) 2013-10-11 2019-09-10 梅尔莎纳医疗公司 蛋白质-聚合物-药物共轭物
CN105813655B (zh) 2013-10-11 2022-03-15 阿萨纳生物科技有限责任公司 蛋白-聚合物-药物缀合物
CA2944699C (fr) * 2014-04-10 2023-05-23 Af Chemicals, Llc Conjugues de medicament et d'element d'affinite
JP6149810B2 (ja) * 2014-06-13 2017-06-21 株式会社島津製作所 代謝物解析システム及び代謝物解析方法
TWI695011B (zh) 2014-06-18 2020-06-01 美商梅爾莎納醫療公司 抗ｈｅｒ２表位之單株抗體及其使用之方法
WO2016050210A1 (fr) 2014-10-01 2016-04-07 厦门赛诺邦格生物科技有限公司 Dérivé de polyéthylène glycol multifonctionnalisé et son procédé de préparation
CN104877127B (zh) 2015-06-23 2017-11-10 厦门赛诺邦格生物科技股份有限公司 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质
WO2017106630A1 (fr) * 2015-12-18 2017-06-22 The General Hospital Corporation Polymères polyacétal, conjugués, particules et utilisations associées
CN109310885B (zh) 2016-03-15 2022-05-31 梅尔莎纳医疗公司 NaPi2b靶向抗体-药物缀合物及其使用方法
CN109563215B (zh) 2016-06-03 2021-11-19 诺灵生物医药科技(北京)有限公司 聚合物连接子及其用途
WO2018160538A1 (fr) 2017-02-28 2018-09-07 Mersana Therapeutics, Inc. Polythérapies de conjugués anticorps-médicament ciblant her2
KR101875321B1 (ko) 2017-03-15 2018-07-05 인하대학교 산학협력단 트리펩타이드 및 다이펩타이드 유도체, 이의 제조방법, 이를 포함하는 화학센서 및 이를 이용한 알루미늄 이온 및 3가 금속이온을 비례 형광형으로 검출하는 방법
JP7320458B2 (ja) 2017-06-22 2023-08-03 メルサナ セラピューティクス インコーポレイテッド 薬物担持ポリマースキャフォールドおよびタンパク質－ポリマー－薬物コンジュゲートを製造する方法
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US93951A (en) * 1869-08-24 Improved die fob forming- carriage-shaft shackles
US152790A (en) * 1874-07-07 Improvement in explosive compounds
US193211A (en) * 1877-07-17 Improvement in car-repiacers
US4793986A (en) 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
JPH01190636A (ja) 1988-01-22 1989-07-31 Green Cross Corp:The 制癌作用物質複合体
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6610841B1 (en) 1997-12-18 2003-08-26 Gilead Sciences, Inc. Nucleotide-based prodrugs
JPH07509467A (ja) * 1992-07-21 1995-10-19 ザ　ゼネラル　ホスピタル　コーポレーション リンパ組織への薬物輸送システム
US5624803A (en) * 1993-10-14 1997-04-29 The Regents Of The University Of California In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5612037A (en) * 1994-07-26 1997-03-18 Connaught Laboratories, Inc. Influenza virus subunit conjugates
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
CA2216844A1 (fr) * 1995-03-31 1996-10-03 Drug Delivery System Institute, Ltd. Derives d'amidite et derives d'oligonucleotides
US5811510A (en) 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
EP0832220A1 (fr) 1995-06-07 1998-04-01 Amgen Inc. Compositions renfermant la proteine ob et procedes associes
JP3737518B2 (ja) 1996-03-12 2006-01-18 ピージー−ティーエックスエル カンパニー， エル．ピー． 水溶性パクリタキセルプロドラッグ
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
NZ515999A (en) * 1999-06-18 2004-03-26 Ml Lab Plc Biologically active materials
IL131074A0 (en) 1999-07-23 2001-03-19 Polygene Ltd A biodegradable polycation composition for delivery of an anionic macromolecule
US8106098B2 (en) * 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
JP4813712B2 (ja) * 1999-08-09 2011-11-09 ザ ジェネラル ホスピタル コーポレーション 薬物−担体複合体およびその使用方法
US6822086B1 (en) * 1999-08-09 2004-11-23 The General Hospital Corporation Drug-carrier complexes and methods of use thereof
WO2002020663A2 (fr) * 2000-09-06 2002-03-14 Ap Pharma, Inc. Polymeres degradables de polyacetal
DE60323936D1 (de) * 2002-01-14 2008-11-20 Gen Hospital Corp Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
EP1585817B1 (fr) * 2002-02-20 2009-09-02 The General Hospital Corporation Conjugues contenant un polymere biodegradable, et leurs utilisations
JP4800614B2 (ja) * 2002-07-19 2011-10-26 ザ ジェネラル ホスピタル コーポレイション オキシム結合体、およびそれらの形成および使用のための方法
WO2004009774A2 (fr) 2002-07-19 2004-01-29 Amgen Inc. Conjugues de proteines avec un polymere biodegradable, biocompatible soluble dans l'eau
ATE533513T1 (de) * 2002-09-06 2011-12-15 Cerulean Pharma Inc Polymere auf basis von cyclodextrin zur verabreichung von an diese kovalent gebundene arzneimittel
EP1608380A2 (fr) 2003-03-31 2005-12-28 Vectramed, Inc. Agents medicamenteux polymeres pour le traitement des affections de type fibrose
DE602004032553D1 (de) * 2003-09-05 2011-06-16 Gen Hospital Corp Polyacetal-arzneimittelkonjugate als freisetzungssystem
EP2217283A2 (fr) * 2007-11-28 2010-08-18 Mersana Therapeutics, Inc. Conjugués d'analogues de fumagilline biocompatibles et biodégradables
WO2010144881A1 (fr) 2009-06-12 2010-12-16 The General Hospital Corporation Traitement de méningites et de maladies neuronales

Also Published As

Publication number Publication date
JP2007504253A (ja) 2007-03-01
EP1667726B1 (fr) 2011-05-04
US20110059010A1 (en) 2011-03-10
US8101164B2 (en) 2012-01-24
WO2005023294A2 (fr) 2005-03-17
US8546419B2 (en) 2013-10-01
DE602004032553D1 (de) 2011-06-16
WO2005023294A3 (fr) 2005-06-09
JP5537763B2 (ja) 2014-07-02
JP2014111657A (ja) 2014-06-19
US20070190018A1 (en) 2007-08-16
CA2537993A1 (fr) 2005-03-17
ES2365918T3 (es) 2011-10-13
CA2537993C (fr) 2012-08-28
ATE507845T1 (de) 2011-05-15
EP1667726A2 (fr) 2006-06-14
AU2004270251A1 (en) 2005-03-17
JP2011153159A (ja) 2011-08-11
US8247427B2 (en) 2012-08-21
AU2004270251B2 (en) 2011-03-31
US7790150B2 (en) 2010-09-07
US20120289535A1 (en) 2012-11-15
US20120004255A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
HK1092708A1 (en) Polyacetal drug conjugates as release system
SG145693A1 (en) Amino acid prodrugs
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
WO2005056572A3 (fr) Produits de recombinaison glucidiques multi-antigeniques groupes, leurs procedes de preparation et leurs utilisations
WO2008076333A3 (fr) Polymères à base de cyclodextrine pour administration d'agents thérapeutiques
IL135148A0 (en) A polysaccharide conjugate and pharmaceutical compositions containing the same
JO2744B1 (en) Cytotoxic agents, including new tomaymycin derivatives and their therapeutic use
HK1077513A1 (en) Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
WO2007064345A3 (fr) Composés de bis-1,8-naphtalimide substitués par un groupe hétérocyclique, conjugués anticorps-médicament et procédés d'utilisation de ceux-ci
EP2357006A3 (fr) Conjugués de médicaments et leur utilisation pour traiter le cancer, maladie auto-immune ou maladie infectieuse
GR3037076T3 (en) Camptothecin derivatives
EP1242115A4 (fr) Immunite chimiquement programmable
DE60323756D1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
NZ600039A (en) Biocompatible biodegradable fumagillin analog conjugates
MXPA03011094A (es) Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
WO2006124737A3 (fr) Produits de synthese moleculaires adaptes a des conjugues cibles
TWI265928B (en) A61k 31/4025 200601 a i htw a61p 25/00 200601 a n htw
WO2007005941A3 (fr) Conjugues cibles sur le foie
WO1998000173A3 (fr) Distribution ciblee de medicaments a l'aide de derives de sulfonamides
CA2703688A1 (fr) Utilisation de conjugues d'acide biliaire ou d'acide gras de sel biliaire
DK1327146T3 (da) Forbindelse med et forgrenet linkermolekyle
EP2161037A3 (fr) Conjugués de Camptothecin-Somatostatin
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
WO2005002516A3 (fr) Conjugues peptides-medicaments integres dans des leucocytes
MX2021003295A (es) Enlazadores basados en sulfomaleimida y sus correspondientes conjugados.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180901